"We try to remember that medicine is for the patient. We try never to forget that medicine is for the people. It is not for the profits. The profits follow, and if we have remembered that, they have never failed to appear. The better we have remembered it, the larger they have been.”
"We try to remember that medicine is for the patient. We try never to forget that medicine is for the people. It is not for the profits. The profits follow, and if we have remembered that, they have never failed to appear. The better we have remembered it, the larger they have been.”
miSerumdx™ Biomarkers for Life
|
Personalised Early Cancer Detection for Oral Cancer
Patients with oral cancers are usually diagnosed late in the disease with advance tumours. These patients often have high treatment related morbidity and only a 50% survival rate after 5 years. The solution is early detection. miSerumdx™, is a blood based diagnostic product for the early detection of oral cancers. Early detection using miSerumdx™ will result in early intervention. This will empower consumers, our patients to plan effective treatments, improve their quality of life, and significantly reduce therapy cost. We have patents file in Australia, China, US and the EU. For more information please contact Dr Nham Tran (nham.tran@uts.edu.au) |
Empowering those who need it most
|
|
|
|
Blood Based Diagnostic The miSerumdx™ suite of markers are found in serum. Due to their structure they will not degrade in blood sampling or in storage conditions for up to 10 yrs. |
Testing in the lab - Results in 48hrs The serum markers are detected with high sensitivity and specificity. We have developed a qPCR assay measuring the specific amounts of these markers in the blood. |
Consultation with health professionals miSerumdx™ has the potential to shift the current diagnostic approach for Oral Cancer. miSerumdx™ rapidly diagnoses patients much earlier, resulting in improved quality of life. |